Medtronic (MDT) Tops Q3 EPS by 4c; raises FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medtronic (MDT) gains after boosting full-year guidance
February 20, 2024 7:18 AM ESTMedtronic (NYSE: MDT) shares rose 4.25% after the medical device maker reported third-quarter earnings that topped analyst estimates and raised its revenue and earnings guidance for fiscal year 2024. The company's adjusted EPS of $1.30 was $0.04 higher than the consensus estimate of $1.26, while revenue for the quarter came in at $8.1 billion, surpassing the $7.95 billion expected by analysts.
The reported revenue marked a 4.7% increase on a... More
